GlassScriptPhysician profile
Harry Anastos
NPI 1851895353
$28,883.21
in general payments reported to CMS, 2019-2025
13 companies · $728 in 2025
The $728 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $27K · 2024: $1,511 · 2025: $728.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $25K · Food and Beverage: $3,725 · Education: $158.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $25,000.00 |
| Food and Beverage | $3,725.40 |
| Education | $157.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $26,766.37 | 2023-2025 | General - Kidney Stone Disease, Lithoclast, Ams 700 Cxr Rte Kit |
| Urogen Pharma, INC. | $503.95 | 2023-2024 | Jelmyto |
| Coloplast Corp | $340.33 | 2023-2025 | Titan |
| Procept Biorobotics Corporation | $332.97 | 2024-2025 | Aquabeam System |
| Sumitomo Pharma America, INC. | $205.93 | 2023-2024 | Gemtesa |
| Ferring Pharmaceuticals INC. | $167.51 | 2025 | Adstiladrin |
| Calyxo, INC. | $157.63 | 2023-2025 | Cvac Aspiration System |
| Olympus America INC. | $150.00 | 2023 | Itind System |
| Laborie Medical Technologies Corp. | $99.73 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Janssen Biotech, INC. | $89.04 | 2025 | Erleada |
| Immunitybio, INC. | $27.32 | 2024 | |
| Intuitive Surgical, INC. | $23.66 | 2023 | Da Vinci Surgical System |
| Progenics Pharmaceuticals, INC. | $18.77 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harry Anastos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.